Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shuper, A.
Right arrow Articles by Tiqva, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shuper, A.
Right arrow Articles by Tiqva, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Subacute Central Nervous System Degeneration in a Child: An Unusual Manifestation of Ifosfamide Intoxication

Avinoam Shuper, MD

Pediatric Hematology- Oncology Institute, icohen@ccsg/tau.ac.il

Jeremiah Stein, MD

Pediatric Hematology- Oncology Institute

Jacob Goshen, MD

Institute of Nuclear Medicine

Liora Kornreich, MD

Department of Pediatric Imaging

Izhak Yaniv, MD

Pediatric Hematology-Oncology Institute Schneider Children's Medical Center of Israel

Ian J. Cohen, MB, ChB

Pediatric Hematology-Oncology Institute Schneider Children's Medical Center of Israel

Petah Tiqva

Sackler Faculty of Medicine Tel Aviv University Tel Aviv, Israel

A 5-year-old child with desmoplastic small round-cell tumor was treated with a protocol of very-high-dose, short-term chemotherapy, containing HD-CAV (cyclophosphamide, doxorubicin, vincristine, and mesna), ifosfamide, and etoposide. Two days after the initiation of ifosfamide, he exhibited new-onset lethal encephalopathy manifested by subacutely progressive cerebellar and then temporal and frontocortical degeneration leading to a vegetative state and eventually to death. A full work-up, including brain biopsy, was negative, excluding infections and metabolic or vascular causes. Ifosfamide is known to be capable of causing acute encephalopathy that can be severe but is generally reversible. This child showed a very atypical progressive, lethal course of ifosfamide toxicity. The possibility of this complication should be considered when high-dose ifosfamide treatment is planned for children. (J Child Neurol 2000;15:481-483).

Journal of Child Neurology, Vol. 15, No. 7, 481-483 (2000)
DOI: 10.1177/088307380001500711
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?